VBS Journal Club

Written by: Daniel Su, MD June 2020 Grewal DS, Charles S, Parolini B, Kadonosono K, Mahmoud TH. Autologous Retinal Transplant for Refractory Macular Holes: Multicenter International Collaborative Study Group. Ophthalmology 2019 Oct;126(10):1399-1408 Single surgery success rates are high for primary macular holes and are often reported to be higher than 90%. Modern techniques typically involve […]

Written by: Rehan M. Hussain, MD June 2020 Pasu S, Bell L, Zenasni Z, et al; The Positioning in Macular Hole Surgery (PIMS) Study Group. Facedown positioning following surgery for large full-thickness macular hole: a multicenter randomized clinical trial. JAMA Ophthalmol. Published online May 7, 2020. doi:10.1001/jamaophthalmol. 2020.0987 Smiddy WE, Flynn HW Jr, Vanner EA. […]

Written by: Vlad Matei, MD June 2020 Elhusseiny AM, Schwartz SG, Flynn HW Jr, Smiddy WE. Long-term outcomes after macular hole surgery. Ophthalmol Retina 2020;4(4):369-376. Best-corrected visual acuity (BCVA) can continue to improve during at least the first year after pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling for idiopathic full-thickness macular hole […]

Written by: Akshay S. Thomas, MD May 2020 Miller AG, Chandra R, Pophal C, Schartman JP, Hornik JH, Miller DG. Efficacy of Macular Hole Surgery in Patients with Idiopathic Macular Telangiectasia Type 2. Ophthalmol Retina. 2020;4(5):494-497. Idiopathic macular telangiectasia (IMT) type 2 is a neurodegenerative retinal disorder that can occasionally lead to full-thickness macular hole […]

Written by: Avni P. Finn, MD May 2020 Casswell EJ, Yorston D, Lee E, et al. Effect of Face-Down Positioning vs Support-the-Break Positioning After Macula-Involving Retinal Detachment Repair: The PostRD Randomized Clinical Trial. JAMA Ophthalmol. Published online April 16, 2020. There is a lack of consensus among vitreoretinal surgeons in regard to the optimal positioning for patients after […]

Written by: Joshua D. Levinson, MD May 2020 Yeh S, Khurana RN, Shah M, et al. Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial [published online ahead of print, 2020 Jan 10]. Ophthalmology. 2020;S0161-6420(20)30011-7. doi:10.1016/j.ophtha.2020.01.006 Noninfectious uveitis (NIU) may impair vision due to macular edema and intraocular […]

Written by: Jeremy Lavine, MD, PhD April 2020 Hsu J, Patel SN, Wolfe JD, et al. Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol. 2020 Apr 2. doi: 10.1001/jamaophthalmol.2020.0724. [Epub ahead of print] Anti-vascular endothelial growth factor (VEGF) therapy is the gold standard for neovascular age-related macular degeneration (nvAMD). Despite monthly injections, […]

Written by: Judy Chen, MD April 2020 He Y, Zhang L, Wang F, et al. Timing influence of outcomes of vitrectomy for open-globe injury: A prospective randomized comparative study.  Retina April 2020; 40:725-734. Ocular trauma is still one of the leading causes of blindness and visual impairment worldwide.  Many incidences of open-globe injury involve damage […]